Anna French is a Managing Partner at Qiming Venture Partners USA. She previously worked as a healthcare management consultant at Boston Consulting Group.

What Anna can write

Writes checks of$1M to $10M
Comes in atPre-seed, Seed, Series A, Series BCan lead the round
Ownership target7-10%At first check
Pitch pageSubmit on their siteThe firm asks founders to apply here.

Qiming Venture Partners USA writes $1M to $10M checks, larger than 83% of firms in the atlas.

Bars: how many firms report each check band. Highlighted: Qiming Venture Partners USA.

Career

  1. Centre for the Advancement of Sustainable Medical Innovation (CASMI)’s Translational Stem Cell Consortium
  2. Boston Consulting Group · healthcare management consultant
  3. Qiming Venture Partners USA · Managing Partner
    Now

Investments named in public bios

Umoja BiopharmaEmpirico Inc.Renasant BioAuron TherapeuticsEntact BioCadent TherapeuticsJasper Therapeutics

Focus

biotechhealthcareadvanced therapiescell therapystem cell research

Education

University of Bristol, BSc in BiochemistryUniversity of Oxford, D.Phil.

Also at Qiming Venture Partners USA

Partners like Anna

At firms with a similar stage, sector and check size.

Alert me when Qiming Venture Partners USA is active

One email when Anna's firm raises a fund, adds a partner or shows new activity.

Founders and investors at a Mode VC gathering

Send Mode VC your deck

Raising a pre-seed or seed round? We write $1M to $5M first checks and help founders with distribution. A partner reads every deck.

Send your deck

Questions

Who is Anna French?

Anna French is a Managing Partner at Qiming Venture Partners USA. She previously worked as a healthcare management consultant at Boston Consulting Group.

How much does Anna French invest?

Anna French invests through Qiming Venture Partners USA, which writes checks of $1M to $10M at pre-seed, seed, series a, series b.

How do I pitch Anna French?

A warm intro from a founder Qiming Venture Partners USA backed works best.

What did Anna French do before Qiming Venture Partners USA?

Centre for the Advancement of Sustainable Medical Innovation (CASMI)’s Translational Stem Cell Consortium; healthcare management consultant at Boston Consulting Group.

Last updated 2026-10-15. Is this you? Ask for a correction.